Brianna Hoffner reminds oncology nurses to collaborate with colleagues in other departments when treating patients with immune-related adverse events.
Brianna Hoffner, MSN, NP, RN, of the University of Colorado Cancer Center reminds nurses: "you're not an island," and emphasizes collaboration when treating patients with immune-related adverse events.
It's easy for oncology nurses to take on all the work themselves as they are used to managing so much of a patient's treatment. However, when it comes to complex immune-related adverse events, Hoffner encourages nurses to network with colleagues in other departments. Those specialists can advise on the best approaches for treatment.
Pembrolizumab in Addition to Cisplatin and Gemcitabine Boosts Overall Survival in Advanced Biliary Tract CancerApril 20th 2023
Patients who received pembrolizumab plus cisplatin and gemcitabine achieved a median overall survival of 12.7 months, compared with 10.9 months with cisplatin and gemcitabine alone.
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
Improvements in Health Systems Model Reduces Disparities in Leukemia Survival in Low-Income Countries
Telephone and Web-Based Program Elicits Clinically Meaningful Results in Breast Cancer Survivors
Luspatercept Elicits High Transfusion Independence Rates in Lower-Risk MDS
2 Clarke Drive
Cranbury, NJ 08512